TUESDAY, Oct. 21, 2025 (HealthDay News) -- For patients with metastatic castration-sensitive prostate cancer (mCSPC) with homologous recombination repair (HRR)
Niraparib Plus AAP Improves Survival in mCSPC With HRR Gene Alterations
HealthDay3 hrs ago
146
KTVN
Atlanta Black Star Entertainment
AlterNet
The Conversation
Providence Journal Sports
Raw Story
The Hill